Skip to content
Screener

Collegium Pharmaceutical, Inc. COLL Operating Lease Liabilities (Total)

Discontinued — last reported Q4 '25

Operating Lease Liabilities (Total) at other companies

Indivior Pharmaceuticals, Inc. logo
Indivior Pharmaceuticals, Inc.INDV
$32M-23.8%
Scilex Holding Company logo
Scilex Holding CompanySCLX
$14.57M+605%
Pacira BioSciences, Inc. logo
Pacira BioSciences, Inc.PCRX
$43.52M-18.0%
Bioventus logo
BioventusBVS
$6.11M-34.8%
Dogwood Therapeutics logo
Dogwood TherapeuticsDWTX
$144.93K-24.2%
Cumberland Pharmaceuticals logo
Cumberland PharmaceuticalsCPIX
$4.71M-7.6%

Segments

By geography

See full
Stoughton, Massachusetts$5.01M—

Other financials

Income statement

See full
Revenue$199.9M+6.3%
Gross profit$110.3M+1.8%
Operating income$3.7M-89.5%
Net income-$15.1M-226%
EPS (diluted)-$0.46-235%

Balance sheet

See full
Cash & equivalents$150.4M+8.8%
Total debt$5.0M-19.8%
Total equity$311.9M+34.3%
Total assets$2.1B+34.1%

Cash flow

See full
Operating cash flow$71.3M-1.5%
CapEx$496.0K+663%
Free cash flow$70.8M-2.1%

Valuation

See full
Market cap$955.82M-22.5%
Enterprise value$810.41M-26.8%
P/E20×-14.1×
P/S1.2×-0.6×

Profitability

See full
Gross margin60%+3.3pp
Operating margin19.5%+1.1pp
Net margin5.9%+0.8pp
FCF margin40.6%+10.8pp

Returns & leverage

See full
Return on equity17.6%+1.4pp
Debt / equity0×0.0×
Current ratio1×-0.2×

Where this comes from

Reported directly by Collegium Pharmaceutical, Inc. in its filing.

Tagged under the XBRL concept us-gaap:OperatingLeaseLiability.

The source filing: Collegium Pharmaceutical, Inc.’s 10-K, filed February 26, 2026.

Filed
Feb 26, 2026, 7:34 AM EST
Fiscal year
FY2025
Accession
0001628280-26-011992

As of December 31, 2025 and 2024, the Company's operating lease assets totaled $4,187 and $5,822, respectively, and operating lease liabilities totaled $5,539 and $6,810, respectively. This primarily relates to the Company’s corporate headquarters lease in Stoughton, Massachusetts and the Ironshore Lease.

Item 16. Form 10-K Summary

FAQ

What is Collegium Pharmaceutical, Inc.'s operating lease liabilities (total)?
Collegium Pharmaceutical, Inc. (COLL) reported operating lease liabilities (total) of $5.54M in Q4 2025.
How has Collegium Pharmaceutical, Inc.'s operating lease liabilities (total) changed year-over-year?
Collegium Pharmaceutical, Inc.'s operating lease liabilities (total) decreased by 18.7% year-over-year, from $6.81M to $5.54M.
What is the long-term trend for Collegium Pharmaceutical, Inc.'s operating lease liabilities (total)?
Over 5 years (2020 to 2025), Collegium Pharmaceutical, Inc.'s operating lease liabilities (total) has grown at a -10.2% compound annual growth rate (CAGR), from $9.5M to $5.54M.
What does operating lease liabilities (total) mean?
This represents the total present value of future lease payments for operating leases, recognized as a liability on the balance sheet. It reflects the company's long-term commitment to leased assets such as office space, warehouses, and equipment. Tracking this helps investors evaluate the company's off-balance-sheet financing obligations and overall debt-like commitments.

Ask your AI about Collegium Pharmaceutical, Inc.'s operating lease liabilities (total).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude